Greater Occipital Nerve Block for Migraine with Medication Overuse Headache
Run by Mahidol University · NCT07568496 · Data updated 2026-11-12
This study will test whether a nerve block using lidocaine and methylprednisolone can help people with migraine who overuse medications to reduce withdrawal headaches during detoxification.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 80 Years |
| Sex | All |
| Enrollment | 130 (estimated) |
| Sponsor | Mahidol University Academic / other |
| Locations | 3 sites (Bangkok, Bangkok and 2 other locations) |
| Status | Recruiting |
| Started | May 12, 2026 |
| Main results expected | November 1, 2028 |
| Study ends | November 1, 2028 |
| Registry record updated | October 8, 2026 |
| Trial ID | NCT07568496 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Women with migraine and medication overuse headache who meet ICHD-3 criteria and have no contraindicating conditions.
✕Probably not a fit
Patients with non-migraine headaches, certain medical contraindications, or those on CGRP therapies or botulinum toxin may not benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This interventional study evaluates the efficacy of a greater occipital nerve block (GONB) as a bridging therapy for detoxification in patients with migraine and medication overuse headache (MOH). Participants will receive either lidocaine with methylprednisolone or placebo, as part of a detoxification plan across three Thai headache centers from February 2026 to January 2028. The trial targets adults diagnosed with MOH per ICHD-3 criteria, excluding those with other headache types, certain medical histories, or current CGRP/botulinum toxin therapies. Outcomes will inform whether GONB can reduce withdrawal-related headache and support MOH treatment strategies. The research is sponsored by Mahidol University with collaborators from three universities.
Why it matters
Potential benefit: If successful, GONB could become a viable option to ease detoxification and reduce headache days during MOH treatment.
How similar studies have gone: Prior data support GONB for chronic migraine, but this is a placebo-controlled evaluation specifically for MOH.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients who have a diagnosis of migraine with medication overuse headache according to ICHD-3 criteria confirmed by a neurologist * Female patients will be screened for pregnancy planning and married female patients must undergo a urine pregnancy test Exclusion Criteria: * Patients who have other types of headache disorders other than migraine * Patients who have a previous history of allergy to corticosteroid or lidocaine * Patients who had previous skull surgery * Pregnant women * Patients with a history of uncontrolled depression, or psychosis * Patients who get or plan to get CGRP-targeted therapies or botulinum toxin injection * Patients with an increased risk of bleeding or underlying bleeding disorders
Where it's running
-
Faculty of Medicine Siriraj Hospital, Mahidol University
Bangkok, Bangkok, Thailand Recruiting -
Faculty of Medicine, Prince of Songkla University
Hat Yai, Changwat Songkhla, Thailand Recruiting -
Faculty of Medicine, Chiang Mai University
Chiang Mai, Chiang Mai, Thailand Not yet recruiting
Study contacts
- Study coordinator: Pannathat Soontrapa, M.D.
- Email: pannathat.soo@mahidol.ac.th
- Phone: +6690-568-6388
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
HEADS Registry: Headache, Ear, Auditory, Dizziness, and Sinus</n> Registry
This registry tests whether collecting online symptom reports from adults in the U.S. with sinus, vestibular, ear, or headache symptoms can help improve diagnosis and treatment.
-
MMA Embolization for Migraine: Patient-Reported Outcomes from a Single Site
This registry tests whether adults with migraine who have or plan to have middle meningeal artery embolization notice changes in headaches and quality of life over time.
-
Personalized pulsed radiofrequency treatment of the greater occipital nerve for medication overuse headache
This trial will try pulsed radiofrequency applied to the greater occipital nerve, given either early or after an initial month of standard care, to see if it reduces monthly headache days in adults with medication overuse headache.
-
Myofascial trigger point steroid injection versus greater occipital nerve block for chronic migraine
This trial will test whether steroid injections into myofascial trigger points work as well as greater occipital nerve block for adults (18–65) with chronic migraine who still have moderate pain despite treatment.
-
Closing a PFO to improve glymphatic function and migraine symptoms
This study will see if closing a patent foramen ovale (PFO) improves glymphatic system function and reduces migraine attacks in adults with PFO and migraine.
-
Italian Migraine Registry (I-GRAINE-NEW)
This registry will collect past and future clinical and healthcare data from adults with episodic or chronic migraine who come to specialized headache centers in Italy to better understand how the condition evolves and is treated.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.